The treatment of PDAC requires novel targets and increasing interest in research regarding novel cancer biomarkers has been focused on the GST family which contributes to the malignant phenotype of many cancers
Interestingly, this effect appears to be context-dependent, that is, robust in vivo, but not consistently observed in isolated in vitro models
Without adequate training, results will disappoint
Nature 508 (7495), 258262
2007, Varma et al
Do you want a Band-Aid or a real fix? Choice reframes from if to which path Ethical care plans Clinically justified, transparent costs and expectations, measurable goals, documented progress, individualized adjustments, informed consent Include family/caregivers when appropriate